Position in MRK
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$884,080
+$99,188 QoQ
Shares Held
6,880
+5.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.44%
of 13F equity value
Holder Rank
#2,224
of 3,769 holders
Holding Since
Dec 2022
10 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026RIVERSEDGE ADVISORS, LLC holds $8,081,117 across 10 Drug Manufacturers - General names. MRK ranks #5 (10.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
6,231 | $1,582,487 | |
| 2 | LLY |
ELI LILLY & Co
|
1,159 | $1,390,139 | |
| 3 | ABBV |
AbbVie Inc.
|
4,666 | $1,174,152 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
19,575 | $1,127,911 | |
| 5 | MRK |
Merck & Co., Inc.
This page
|
6,880 | $884,080 | |
| 6 | NVS |
Novartis AG
|
3,883 | $608,543 | |
| 7 | AZN |
Astrazeneca PLC
|
2,280 | $432,333 | |
| 8 | BIIB |
Biogen Inc.
|
1,746 | $377,240 |
All Filings in MRK
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $884,080 | 6,880 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $784,892 | 6,525 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $653,875 | 6,212 | Shares | Sole | 2026-01-07 | |
| 2025-09-30 | $490,067 | 5,839 | Shares | Sole | 2025-10-09 | |
| 2024-09-30 | $235,864 | 2,077 | Shares | Sole | 2024-10-16 | |
| 2024-06-30 | $314,328 | 2,539 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $345,313 | 2,617 | Shares | Sole | 2024-04-30 | |
| 2023-12-31 | $270,805 | 2,484 | Shares | Sole | 2024-01-17 | |
| 2023-06-30 | $207,586 | 1,799 | Shares | Sole | 2023-07-13 | |
| 2022-12-31 | $207,032 | 1,866 | Shares | Sole | 2023-01-20 | |
| No filing history on record for this holder in this stock. | ||||||